Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.
28 November 2018Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).
12 September 2016